Domestic sales forecast to rise in second half

Published: 2004-10-01 07:00:00

Updated: 2004-10-01 07:00:00

Domestic pharmaceutical sales are expected to show sustained signs of recovery in the second half of the year but with low profitability, said Chung Myung-jin, an analyst at Daeshin Economic Institute.

The analyst said he expects total pharmaceutical sales growth to 7.7 percent in the second h...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK